Mile High Labs has announced $35m in Series A funding from institutional and private equity investors.

The Colorado US-based company, which claims to be the leading cannabinoid extractor in the world, says this is the largest Series A financing in the history of the cannabis market.

Series A funding typically refers to a company’s first significant round of venture capital financing – though how exactly a company defines “first” and “significant” can differ from case to case. In this instance Mile High said it will use its Series A funding to expand production capacity of CBD extracts in order to meet increasing demand.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us